Kuehnel Nicholas A, McCreary Erin, Henderson Sheryl L, Vanderloo Joshua P, Hoover-Regan Margo L, Sharp Brian, Ross Joshua
From the Department of Emergency Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pa.
Pediatr Qual Saf. 2021 Feb 12;6(2):e390. doi: 10.1097/pq9.0000000000000390. eCollection 2021 Mar-Apr.
Rapid time to antibiotics (TTA) for pediatric patients with fever and neutropenia in an emergency department decreases in-hospital mortality. Additionally, national guidelines recommend outpatient antibiotic management strategies for low-risk fever and neutropenia (LRFN). This study had two specific aims: (1) improve the percent of patients with suspected fever and neutropenia who receive antibiotics within 60 minutes of arrival from 55% to 90%, and (2) develop and operationalize a process for outpatient management of LRFN patients by October 2018.
Using Lean methodologies, we implemented Plan-Do-Check-Act cycles focused on guideline development, electronic medical record reminders, order-set development, and a LRFN pathway as root causes for improvements. We used statistical process control charts to assess results.
The project conducted from July 2016 to October 2018 showed special cause improvement in December 2016 on a G-chart. Monthly Xbar-chart showed improvement in average TTA from 68.5 minutes to 42.5 minutes. A P-chart showed improvement in patients receiving antibiotics within 60 minutes, from 55% to 86.4%. A LRFN guideline and workflow was developed and implemented in October 2017.
Implementation of guidelines, electronic medical record reminders, and order sets are useful tools to improve TTA for suspected fever and neutropenia. Utilizing more sensitive statistical process control charts early in projects with fewer patients can help recognize and guide process improvement. The development of workflows for outpatient management of LRFN may be possible, though it requires further study.
对于急诊科中发热且中性粒细胞减少的儿科患者,快速给予抗生素治疗(TTA)可降低住院死亡率。此外,国家指南推荐针对低风险发热和中性粒细胞减少(LRFN)采用门诊抗生素管理策略。本研究有两个具体目标:(1)将疑似发热和中性粒细胞减少患者在到达后60分钟内接受抗生素治疗的比例从55%提高到90%,(2)到2018年10月制定并实施LRFN患者门诊管理流程。
我们采用精益方法,实施计划-执行-检查-行动循环,重点关注指南制定、电子病历提醒、医嘱集开发以及LRFN路径,将其作为改进的根本原因。我们使用统计过程控制图来评估结果。
2016年7月至2018年10月开展的该项目在2016年12月的G图上显示出特殊原因导致的改进。月度Xbar图显示平均TTA从68.5分钟改善至42.5分钟。P图显示在60分钟内接受抗生素治疗的患者比例从55%提高到86.4%。2017年10月制定并实施了LRFN指南和工作流程。
实施指南、电子病历提醒和医嘱集是改善疑似发热和中性粒细胞减少患者TTA的有用工具。在患者较少的项目早期使用更敏感的统计过程控制图有助于识别和指导流程改进。虽然可能需要进一步研究,但LRFN患者门诊管理工作流程的开发或许可行。